Rocuronium Bromide Injection, Solution
Product Images NDC 71872-7344

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 71872-7344). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7344.pdp (7344)

7344.pdp (7344)
This is a description of Rocuronium Bromine Injection in a 50 mg/5mL (10 mg/mL) multiple-dose vial. It contains Rocuronium bromide 10 mg and sodium acetate 2 mg. The warning indicates that it is for intravenous use only by healthcare professionals. The storage conditions require keeping it between 2°C and 8°C, and it should not be frozen. The shelf life after reconstitution is 60 days. The product is manufactured by Gapin St Lind in Gumidipoon. Detailed usage instructions are available on the package, and caution is advised for proper administration.*
FDA Label Image

7344m.pdp (7344m)

7344m.pdp (7344m)
This is a product description for Rocuronium Bromide Injection, a paralyzing agent used for intravenous use. It comes in a 5 mL multiple-dose vial with a concentration of 50 mg/5 mL (10 mg/mL). The warning indicates that it can cause respiratory arrest, so facilities for artificial respiration must be readily available. It is sterile and nonpyrogenic. The storage instructions include keeping it in a refrigerator at 2° to 8°C (36° to 46°F) and using it within 60 days if stored at room temperature. The manufacturer is Caplin Steriles Limited in India, and it is distributed by BE Pharmaceuticals Inc. in Cary, North Carolina. The batch number and expiration date are also provided.*
FDA Label Image

Figure1 (Rocurofigure1)

Figure1 (Rocurofigure1)
This text provides age ranges for data analysis: 18-64 years old and 65 years and older. It seems to be related to categorizing individuals based on age for a study or research purpose.*
FDA Label Image

Figure2 (Rocurofigure2)

FDA Label Image

Figure3 (Rocurofigure3)

FDA Label Image

Structure (Rocurostrucaplin)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.